SB 838 – CaliforniaStatus: Enacted
Year Introduced: 2022
Health care: insulin manufacturing.
Existing law requires the California Health and Human Services Agency to enter into partnerships to increase patient access to affordable drugs, including partnerships to produce or distribute generic prescription drugs and at least one form of insulin, if a viable pathway for manufacturing a more affordable form of insulin exists at a price that results in savings.
This bill would eliminate that viability requirement.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.